Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates high-fat diet-induced adipocyte hypertrophy and systemic glucose intolerance in mice

Yoshihiko Kitada, Kazuo Kajita, Koichiro Taguchi, Ichiro Mori, Masahiro Yamauchi, Takahide Ikeda, Mikako Kawashima, Motochika Asano, Toshiko Kajita, Tatsuo Ishizuka, Yoshiko Banno, Itaru Kojima, Jerold Chun, Shotaro Kamata, Isao Ishii, Hiroyuki Morita

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Sphingosine 1-phosphate (S1P) is known to regulate insulin resistance in hepatocytes, skeletal muscle cells, and pancreatic -cells. Among its 5 cognate receptors (S1pr1-S1pr5), S1P seems to counteract insulin signaling and confer insulin resistance via S1pr2 in these cells. S1P may also regulate insulin resistance in adipocytes, but the S1pr subtype(s) involved remains unknown. Here, we investigated systemic glucose/insulin tolerance and phenotypes of epididymal adipocytes in high-fat diet (HFD)-fed wild-type and S1pr2-deficient (S1pr2/) mice. Adult S1pr2/ mice displayed smaller body/epididymal fat tissue weights, but the differences became negligible after 4 weeks with HFD. However, HFD-fed S1pr2/ mice displayed better scores in glucose/insulin tolerance testsandhadsmaller epididymal adipocytes that expressed higher levels of proliferating cell nuclear antigen than wild-type mice. Next, proliferation/differentiation of 3T3-L1 and 3T3-F442A preadipocytes were examined in the presence of various S1pr antagonists: JTE-013 (S1pr2 antagonist), VPC-23019 (S1pr1/S1pr3 antagonist), and CYM-50358 (S1pr4 antagonist). S1P or JTE-013 treatment of 3T3-L1 preadipocytes potently activated their proliferation and Erk phosphorylation, whereas VPC-23019 inhibited both of these processes, and CYM-50358 had no effects. In contrast, S1P or JTE-013 treatment inhibited adipogenic differentiation of 3T3-F442A preadipocytes, whereas VPC-23019 activated it. The small interfering RNA knockdown of S1pr2 promoted proliferation and inhibited differentiation of 3T3-F442A preadipocytes, whereas that of S1pr1 acted oppositely. Moreover, oral JTE-013 administration improved glucose tolerance/insulin sensitivity in ob/ob mice. Taken together, S1pr2 blockade induced proliferation but suppressed differentiation of (pre)adipocytes both in vivo and in vitro, highlighting a novel therapeutic approach for obesity/ type 2 diabetes.

Original languageEnglish
Pages (from-to)1839-1851
Number of pages13
JournalEndocrinology
Volume157
Issue number5
DOIs
Publication statusPublished - 2016 May 1

Fingerprint

Lysosphingolipid Receptors
Glucose Intolerance
High Fat Diet
Adipocytes
Hypertrophy
Insulin Resistance
Insulin
Glucose
Proliferating Cell Nuclear Antigen
Muscle Cells
Type 2 Diabetes Mellitus
Small Interfering RNA
Hepatocytes
Skeletal Muscle
Obesity
Fats
Phosphorylation
sphingosine 1-phosphate
Phenotype
Weights and Measures

ASJC Scopus subject areas

  • Endocrinology

Cite this

Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates high-fat diet-induced adipocyte hypertrophy and systemic glucose intolerance in mice. / Kitada, Yoshihiko; Kajita, Kazuo; Taguchi, Koichiro; Mori, Ichiro; Yamauchi, Masahiro; Ikeda, Takahide; Kawashima, Mikako; Asano, Motochika; Kajita, Toshiko; Ishizuka, Tatsuo; Banno, Yoshiko; Kojima, Itaru; Chun, Jerold; Kamata, Shotaro; Ishii, Isao; Morita, Hiroyuki.

In: Endocrinology, Vol. 157, No. 5, 01.05.2016, p. 1839-1851.

Research output: Contribution to journalArticle

Kitada, Y, Kajita, K, Taguchi, K, Mori, I, Yamauchi, M, Ikeda, T, Kawashima, M, Asano, M, Kajita, T, Ishizuka, T, Banno, Y, Kojima, I, Chun, J, Kamata, S, Ishii, I & Morita, H 2016, 'Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates high-fat diet-induced adipocyte hypertrophy and systemic glucose intolerance in mice', Endocrinology, vol. 157, no. 5, pp. 1839-1851. https://doi.org/10.1210/en.2015-1768
Kitada, Yoshihiko ; Kajita, Kazuo ; Taguchi, Koichiro ; Mori, Ichiro ; Yamauchi, Masahiro ; Ikeda, Takahide ; Kawashima, Mikako ; Asano, Motochika ; Kajita, Toshiko ; Ishizuka, Tatsuo ; Banno, Yoshiko ; Kojima, Itaru ; Chun, Jerold ; Kamata, Shotaro ; Ishii, Isao ; Morita, Hiroyuki. / Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates high-fat diet-induced adipocyte hypertrophy and systemic glucose intolerance in mice. In: Endocrinology. 2016 ; Vol. 157, No. 5. pp. 1839-1851.
@article{08d4ad38042e4d33aeca652302998159,
title = "Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates high-fat diet-induced adipocyte hypertrophy and systemic glucose intolerance in mice",
abstract = "Sphingosine 1-phosphate (S1P) is known to regulate insulin resistance in hepatocytes, skeletal muscle cells, and pancreatic -cells. Among its 5 cognate receptors (S1pr1-S1pr5), S1P seems to counteract insulin signaling and confer insulin resistance via S1pr2 in these cells. S1P may also regulate insulin resistance in adipocytes, but the S1pr subtype(s) involved remains unknown. Here, we investigated systemic glucose/insulin tolerance and phenotypes of epididymal adipocytes in high-fat diet (HFD)-fed wild-type and S1pr2-deficient (S1pr2/) mice. Adult S1pr2/ mice displayed smaller body/epididymal fat tissue weights, but the differences became negligible after 4 weeks with HFD. However, HFD-fed S1pr2/ mice displayed better scores in glucose/insulin tolerance testsandhadsmaller epididymal adipocytes that expressed higher levels of proliferating cell nuclear antigen than wild-type mice. Next, proliferation/differentiation of 3T3-L1 and 3T3-F442A preadipocytes were examined in the presence of various S1pr antagonists: JTE-013 (S1pr2 antagonist), VPC-23019 (S1pr1/S1pr3 antagonist), and CYM-50358 (S1pr4 antagonist). S1P or JTE-013 treatment of 3T3-L1 preadipocytes potently activated their proliferation and Erk phosphorylation, whereas VPC-23019 inhibited both of these processes, and CYM-50358 had no effects. In contrast, S1P or JTE-013 treatment inhibited adipogenic differentiation of 3T3-F442A preadipocytes, whereas VPC-23019 activated it. The small interfering RNA knockdown of S1pr2 promoted proliferation and inhibited differentiation of 3T3-F442A preadipocytes, whereas that of S1pr1 acted oppositely. Moreover, oral JTE-013 administration improved glucose tolerance/insulin sensitivity in ob/ob mice. Taken together, S1pr2 blockade induced proliferation but suppressed differentiation of (pre)adipocytes both in vivo and in vitro, highlighting a novel therapeutic approach for obesity/ type 2 diabetes.",
author = "Yoshihiko Kitada and Kazuo Kajita and Koichiro Taguchi and Ichiro Mori and Masahiro Yamauchi and Takahide Ikeda and Mikako Kawashima and Motochika Asano and Toshiko Kajita and Tatsuo Ishizuka and Yoshiko Banno and Itaru Kojima and Jerold Chun and Shotaro Kamata and Isao Ishii and Hiroyuki Morita",
year = "2016",
month = "5",
day = "1",
doi = "10.1210/en.2015-1768",
language = "English",
volume = "157",
pages = "1839--1851",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates high-fat diet-induced adipocyte hypertrophy and systemic glucose intolerance in mice

AU - Kitada, Yoshihiko

AU - Kajita, Kazuo

AU - Taguchi, Koichiro

AU - Mori, Ichiro

AU - Yamauchi, Masahiro

AU - Ikeda, Takahide

AU - Kawashima, Mikako

AU - Asano, Motochika

AU - Kajita, Toshiko

AU - Ishizuka, Tatsuo

AU - Banno, Yoshiko

AU - Kojima, Itaru

AU - Chun, Jerold

AU - Kamata, Shotaro

AU - Ishii, Isao

AU - Morita, Hiroyuki

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Sphingosine 1-phosphate (S1P) is known to regulate insulin resistance in hepatocytes, skeletal muscle cells, and pancreatic -cells. Among its 5 cognate receptors (S1pr1-S1pr5), S1P seems to counteract insulin signaling and confer insulin resistance via S1pr2 in these cells. S1P may also regulate insulin resistance in adipocytes, but the S1pr subtype(s) involved remains unknown. Here, we investigated systemic glucose/insulin tolerance and phenotypes of epididymal adipocytes in high-fat diet (HFD)-fed wild-type and S1pr2-deficient (S1pr2/) mice. Adult S1pr2/ mice displayed smaller body/epididymal fat tissue weights, but the differences became negligible after 4 weeks with HFD. However, HFD-fed S1pr2/ mice displayed better scores in glucose/insulin tolerance testsandhadsmaller epididymal adipocytes that expressed higher levels of proliferating cell nuclear antigen than wild-type mice. Next, proliferation/differentiation of 3T3-L1 and 3T3-F442A preadipocytes were examined in the presence of various S1pr antagonists: JTE-013 (S1pr2 antagonist), VPC-23019 (S1pr1/S1pr3 antagonist), and CYM-50358 (S1pr4 antagonist). S1P or JTE-013 treatment of 3T3-L1 preadipocytes potently activated their proliferation and Erk phosphorylation, whereas VPC-23019 inhibited both of these processes, and CYM-50358 had no effects. In contrast, S1P or JTE-013 treatment inhibited adipogenic differentiation of 3T3-F442A preadipocytes, whereas VPC-23019 activated it. The small interfering RNA knockdown of S1pr2 promoted proliferation and inhibited differentiation of 3T3-F442A preadipocytes, whereas that of S1pr1 acted oppositely. Moreover, oral JTE-013 administration improved glucose tolerance/insulin sensitivity in ob/ob mice. Taken together, S1pr2 blockade induced proliferation but suppressed differentiation of (pre)adipocytes both in vivo and in vitro, highlighting a novel therapeutic approach for obesity/ type 2 diabetes.

AB - Sphingosine 1-phosphate (S1P) is known to regulate insulin resistance in hepatocytes, skeletal muscle cells, and pancreatic -cells. Among its 5 cognate receptors (S1pr1-S1pr5), S1P seems to counteract insulin signaling and confer insulin resistance via S1pr2 in these cells. S1P may also regulate insulin resistance in adipocytes, but the S1pr subtype(s) involved remains unknown. Here, we investigated systemic glucose/insulin tolerance and phenotypes of epididymal adipocytes in high-fat diet (HFD)-fed wild-type and S1pr2-deficient (S1pr2/) mice. Adult S1pr2/ mice displayed smaller body/epididymal fat tissue weights, but the differences became negligible after 4 weeks with HFD. However, HFD-fed S1pr2/ mice displayed better scores in glucose/insulin tolerance testsandhadsmaller epididymal adipocytes that expressed higher levels of proliferating cell nuclear antigen than wild-type mice. Next, proliferation/differentiation of 3T3-L1 and 3T3-F442A preadipocytes were examined in the presence of various S1pr antagonists: JTE-013 (S1pr2 antagonist), VPC-23019 (S1pr1/S1pr3 antagonist), and CYM-50358 (S1pr4 antagonist). S1P or JTE-013 treatment of 3T3-L1 preadipocytes potently activated their proliferation and Erk phosphorylation, whereas VPC-23019 inhibited both of these processes, and CYM-50358 had no effects. In contrast, S1P or JTE-013 treatment inhibited adipogenic differentiation of 3T3-F442A preadipocytes, whereas VPC-23019 activated it. The small interfering RNA knockdown of S1pr2 promoted proliferation and inhibited differentiation of 3T3-F442A preadipocytes, whereas that of S1pr1 acted oppositely. Moreover, oral JTE-013 administration improved glucose tolerance/insulin sensitivity in ob/ob mice. Taken together, S1pr2 blockade induced proliferation but suppressed differentiation of (pre)adipocytes both in vivo and in vitro, highlighting a novel therapeutic approach for obesity/ type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84969872555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969872555&partnerID=8YFLogxK

U2 - 10.1210/en.2015-1768

DO - 10.1210/en.2015-1768

M3 - Article

AN - SCOPUS:84969872555

VL - 157

SP - 1839

EP - 1851

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -